Objective: This study estimated the risk of all-cause mortality for patients newly prescribed opioids and benzodiazepines concurrently relative to patients prescribed benzodiazepines only, opioids only, or neither medication. Methods: This propensity score-matched, retrospective, cohort study included 17,476 patients receiving Veteran Affairs (VA) health care and diagnosed with posttraumatic stress disorder. One-year total and cause-specific mortality was assessed by hazard ratios and subhazard ratios, adjusted for propensity score, age, baseline mental health and medical comorbidity, and daily medication dose. Findings: Concurrent users (n=4,369) were propensity score matched 1:1 with benzodiazepine only, opioid only, and non-users. In the year following medication start, the concurrent cohort had higher rates of all-cause mortality (116 deaths) relative to benzodiazepine-only (75 deaths; adjusted hazard ratio=1.52, 95% CI, 1.14-2.03), opioid-only (67 deaths; 1.76, 95% CI, 1.32-2.35), and non-user (60 deaths; 1.85, 95% CI, 1.30-2.64) cohorts. Risk of overdose death was greater among patients in the concurrent cohort relative to patients in the benzodiazepine-only (adjusted subhazard ratio=2.59, 95% CI, 1.00-6.66), opioid-only (2.58, 95% CI, 1.09-6.11) and non-user (9.16, 95 CI%, 2.27-37.02) cohorts. For circulatory disease-related deaths, the adjusted subhazard ratio for concurrent medication users was 1.81 (95% CI, 1.01-3.24) relative to non-users. Interpretation: New co-prescription of opioids and benzodiazepines was associated with increased all-cause mortality and overdose death, compared with new prescription of benzodiazepines only, opioids only, or neither medication and increased circulatory disease-related death, relative to neither medication. Strategies are needed to prevent new co-prescribing and facilitate discontinuation among those co-prescribed these medication classes. Funding: Veteran Affairs Health Services Research and Development Declaration of Interest: There are no conflicts of interest to report. Ethical Approval: The study was reviewed and approved by the institutional review board of the VA Puget Sound Health Care System.
Read full abstract